checkAd
    Startseite > Aktien > INmune Bio > Nachrichten
    INmune Bio Aktie
    11,840
     
    USD
    +0,59 %
    +0,070 USD
    Letzter Kurs 30.04.24 Nasdaq
    11,790
     
    USD
    200 STK
    Geldkurs 30.04.24
    11,840
     
    USD
    100 STK
    Briefkurs 30.04.24
    ISIN: US45782T1051 · WKN: A2PCBU · SYM: INMB · USA

    Neueste Nachrichten

    INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro Under Compassionate Use for Over Three Years
    30.04.24 · globenewswire · INmune Bio
    INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    29.04.24 · globenewswire · INmune Bio
    INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    25.04.24 · globenewswire · INmune Bio
    INmune Bio Inc. Announces 24-Month Stability Validation of XPro for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
    23.04.24 · globenewswire · INmune Bio
    INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering
    22.04.24 · globenewswire · INmune Bio
    INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024
    08.04.24 · globenewswire · INmune Bio
    INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
    28.03.24 · globenewswire · INmune Bio
    INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
    26.03.24 · globenewswire · INmune Bio
    INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy
    13.03.24 · globenewswire · INmune Bio
    INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro
    05.03.24 · globenewswire · INmune Bio
    INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    12.02.24 · globenewswire · INmune Bio
    INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
    06.02.24 · globenewswire · INmune Bio